869 related articles for article (PubMed ID: 31567920)
1. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer.
Miyamoto Y; Akiyama T; Kato R; Sawayama H; Ogawa K; Yoshida N; Baba H
Dis Colon Rectum; 2023 Aug; 66(8):e809-e817. PubMed ID: 35195557
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer.
Ahiko Y; Shida D; Nakamura Y; Imaizumi J; Takamizawa Y; Moritani K; Tsukamoto S; Kanemitsu Y
Dis Colon Rectum; 2021 Oct; 64(10):1222-1231. PubMed ID: 33951689
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
[TBL] [Abstract][Full Text] [Related]
6. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection.
Kusunoki K; Toiyama Y; Okugawa Y; Yamamoto A; Omura Y; Ohi M; Araki T; Kusunoki M
Dis Colon Rectum; 2020 Sep; 63(9):1242-1250. PubMed ID: 33216495
[TBL] [Abstract][Full Text] [Related]
7. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
[TBL] [Abstract][Full Text] [Related]
8. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
Lim YJ; Song C; Jeon SH; Kim K; Chie EK
Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
[TBL] [Abstract][Full Text] [Related]
9. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
[TBL] [Abstract][Full Text] [Related]
10. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
[TBL] [Abstract][Full Text] [Related]
11. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
[TBL] [Abstract][Full Text] [Related]
13. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
[TBL] [Abstract][Full Text] [Related]
14. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
[TBL] [Abstract][Full Text] [Related]
16. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
[TBL] [Abstract][Full Text] [Related]
17. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.
Kobayashi Y; Shida D; Boku N; Yasui K; Nakamura Y; Kudose Y; Imaizumi J; Kanemitsu Y
Dis Colon Rectum; 2023 Mar; 66(3):401-409. PubMed ID: 35239524
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Enlarged Lymph Nodes in Stage II Colorectal Cancer.
Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Yamauchi S; Sugihara K; Ishihara S
Dis Colon Rectum; 2023 Nov; 66(11):e1097-e1106. PubMed ID: 37603828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]